TrialPanorama/Dataset huggingface dataset:
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Impact of a PDA-Based Dietary Adherence Intervention on Interdialytic Weight Gain and Blood Pressure in Hemodialysis Patients
Brief Summary: With this study the investigators will test, in a randomised clinical trial (RCT), the efficacy of a behavioral dietary adherence enhancement intervention paired with PDA-based dietary self-monitoring for controlling sodium intake. Seventy hemodialysis patients will be recruited from units in Pittsburgh, Pennsylvania. Participants will be randomized to a 4-month PDA-based dietary counseling intervention or to a 4-month attention control. Potential participants will be stratified by whether or not they have diabetes. Data on primary and secondary outcomes will be obtained at baseline and four months. Primary dependent variables are:

1. adherence to dietary sodium targets as assessed from 3-day food recalls,
2. average monthly interdialytic weight gain, and
3. average pulse pressure. Secondary dependent variables are:
4. adherence to dietary targets for calories, protein, carbohydrates, fats, saturated fats, potassium, and phosphorus, as assessed from 3-day food recalls, (5) serum potassium and phosphorus levels determined on a monthly basis, and (6) nutritional status as determined from serum albumin. Laboratory data, interdialytic weight gain, and blood pressure data will be obtained per dialysis center routine and abstracted from the medical record. Three-day food recalls will be obtained at baseline, 4 and 8 months and analyzed using the Nutrient Data System.


Options:
A: Arm Label: Cohort 1; Type: EXPERIMENTAL; Interventions: Combination Product: VC-01™ Combination Product | Arm Label: Cohort 2; Type: EXPERIMENTAL; Interventions: Combination Product: VC-01™ Combination Product | Intervention Type: COMBINATION_PRODUCT; Name: VC-01™ Combination Product; Assigned to Arm(s): Cohort 1, Cohort 2
B: Arm Label: Sun Protection Education; Type: EXPERIMENTAL; Interventions: Behavioral: Internet-based sun protection education | Arm Label: Control; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Internet-based sun protection education; Assigned to Arm(s): Sun Protection Education
C: Arm Label: Pharmacist intervention; Type: EXPERIMENTAL; Interventions: Other: Pharmacist based QI program | Arm Label: Control - usual care; Type: ACTIVE_COMPARATOR; Interventions: Other: Usual Care | Intervention Type: OTHER; Name: Pharmacist based QI program; Assigned to Arm(s): Pharmacist intervention | Intervention Type: OTHER; Name: Usual Care; Assigned to Arm(s): Control - usual care
D: Arm Label: A; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Standard hemodialysis dietary instruction | Arm Label: B; Type: EXPERIMENTAL; Interventions: Behavioral: Behavioral counseling plus PDA-based self-monitoring of diet | Intervention Type: BEHAVIORAL; Name: Standard hemodialysis dietary instruction; Assigned to Arm(s): A | Intervention Type: BEHAVIORAL; Name: Behavioral counseling plus PDA-based self-monitoring of diet; Assigned to Arm(s): B

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A Phase I/II Trial in Treating Patients With Graft-Versus-Host Disease by the Infusion of Expanded in-Vitro Allogenic Mesenchymal Stem Cell
Brief Summary: Clinical trial based on the use of a new therapeutic strategy (MSC infusion) for the treatment of patients who have developed a GVHD refractory to the usual therapeutic measures after undergoing an allogenic hematopoietic stem cell transplant.


Options:
A: Arm Label: Mesenchymal Stromal Cells (MSC); Type: EXPERIMENTAL; Interventions: Genetic: Mesenchymal stromal cells | Intervention Type: GENETIC; Name: Mesenchymal stromal cells; Assigned to Arm(s): Mesenchymal Stromal Cells (MSC)
B: Intervention Type: PROCEDURE; Name: Mesenchymal stem cell (MSC); Assigned to Arm(s): N/A
C: Arm Label: Autologous hMSCs; Type: ACTIVE_COMPARATOR; Interventions: Biological: Autologous hMSCs | Arm Label: Allogeneic hMSCs; Type: ACTIVE_COMPARATOR; Interventions: Biological: Allogeneic hMSCs | Intervention Type: BIOLOGICAL; Name: Autologous hMSCs; Assigned to Arm(s): Autologous hMSCs | Intervention Type: BIOLOGICAL; Name: Allogeneic hMSCs; Assigned to Arm(s): Allogeneic hMSCs
D: Arm Label: Auto-hMSCs; Type: EXPERIMENTAL; Interventions: Biological: Auto-hMSCs | Arm Label: Allo-hMSCs; Type: EXPERIMENTAL; Interventions: Biological: Allo-hMSCs | Intervention Type: BIOLOGICAL; Name: Auto-hMSCs; Assigned to Arm(s): Auto-hMSCs | Intervention Type: BIOLOGICAL; Name: Allo-hMSCs; Assigned to Arm(s): Allo-hMSCs

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study of Probuphine in Patients With Opioid Dependence
Brief Summary: Buprenorphine (BPN) is an approved treatment for opioid dependence, however, in taking oral tablets, patients experience withdrawal and cravings when the variable BPN levels in the blood are low. Probuphine is an implant placed just beneath the skin that contains BPN. It is designed to provide 6 months of stable BPN blood levels. This study will test the safety and efficacy of Probuphine in the treatment of patients with opioid dependence.


Options:
A: Arm Label: Extended-Release Naltrexone; Type: ACTIVE_COMPARATOR; Interventions: Drug: Extended-Release Naltrexone | Arm Label: Buprenorphine-Naloxone; Type: ACTIVE_COMPARATOR; Interventions: Drug: Buprenorphine-Naloxone | Intervention Type: DRUG; Name: Extended-Release Naltrexone; Assigned to Arm(s): Extended-Release Naltrexone | Intervention Type: DRUG; Name: Buprenorphine-Naloxone; Assigned to Arm(s): Buprenorphine-Naloxone
B: Arm Label: Methadone; Type: ACTIVE_COMPARATOR; Interventions: Drug: Methadone | Arm Label: Buprenorphine/naloxone; Type: EXPERIMENTAL; Interventions: Drug: Buprenorphine/naloxone | Intervention Type: DRUG; Name: Methadone; Assigned to Arm(s): Methadone | Intervention Type: DRUG; Name: Buprenorphine/naloxone; Assigned to Arm(s): Buprenorphine/naloxone
C: Arm Label: 1; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Behavioral: Buprenorphine/naloxone maintenance (Mtn) | Arm Label: 2; Type: EXPERIMENTAL; Interventions: Behavioral: Behavioral: Buprenorphine/naloxone detoxification (Dtx) | Intervention Type: BEHAVIORAL; Name: Behavioral: Buprenorphine/naloxone maintenance (Mtn); Assigned to Arm(s): 1 | Intervention Type: BEHAVIORAL; Name: Behavioral: Buprenorphine/naloxone detoxification (Dtx); Assigned to Arm(s): 2
D: Arm Label: Group A; Type: ACTIVE_COMPARATOR; Interventions: Drug: Probuphine | Arm Label: Group B; Type: PLACEBO_COMPARATOR; Interventions: Drug: placebo | Intervention Type: DRUG; Name: Probuphine; Assigned to Arm(s): Group A | Intervention Type: DRUG; Name: placebo; Assigned to Arm(s): Group B

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study of Probuphine in Patients With Opioid Dependence
Brief Summary: Buprenorphine (BPN) is an approved treatment for opioid dependence, however, in taking oral tablets, patients experience withdrawal and cravings when the variable BPN levels in the blood are low. Probuphine is an implant placed just beneath the skin that contains BPN. It is designed to provide 6 months of stable BPN blood levels. This study will test the safety and efficacy of Probuphine in the treatment of patients with opioid dependence.


Options:
A: Arm Label: Buprenorphine; Type: EXPERIMENTAL; Interventions: Drug: Buprenorphine | Arm Label: Methadone; Type: ACTIVE_COMPARATOR; Interventions: Drug: Methadone | Intervention Type: DRUG; Name: Methadone; Assigned to Arm(s): Methadone | Intervention Type: DRUG; Name: Buprenorphine; Assigned to Arm(s): Buprenorphine
B: Intervention Type: DRUG; Name: Buprenorphine/Subutex; Assigned to Arm(s): N/A | Intervention Type: DRUG; Name: Naltrexone; Assigned to Arm(s): N/A | Intervention Type: PROCEDURE; Name: Drug counseling; Assigned to Arm(s): N/A
C: Arm Label: Group A; Type: ACTIVE_COMPARATOR; Interventions: Drug: Probuphine | Arm Label: Group B; Type: PLACEBO_COMPARATOR; Interventions: Drug: placebo | Intervention Type: DRUG; Name: Probuphine; Assigned to Arm(s): Group A | Intervention Type: DRUG; Name: placebo; Assigned to Arm(s): Group B
D: Intervention Type: DRUG; Name: Buprenorphine/naloxone; Assigned to Arm(s): N/A

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Effect of Yoga Vs. Stretching on Chronic Back Pain
Brief Summary: This study will compare the effectiveness of yoga classes, exercise classes, and a self-care book in the management of pain and function for people with low back pain.It will also for physical, psychological and physiological factors associated with improvement in back pain.


Options:
A: Arm Label: 1; Type: EXPERIMENTAL; Interventions: Procedure: Chiropractic Manual treatment + home exercise (procedure+behavior) | Arm Label: 2; Type: EXPERIMENTAL; Interventions: Procedure: Supervised rehabilitative exercise+home exercise | Arm Label: 3; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Home exercise | Intervention Type: PROCEDURE; Name: Chiropractic Manual treatment + home exercise (procedure+behavior); Assigned to Arm(s): 1 | Intervention Type: PROCEDURE; Name: Supervised rehabilitative exercise+home exercise; Assigned to Arm(s): 2 | Intervention Type: BEHAVIORAL; Name: Home exercise; Assigned to Arm(s): 3
B: Arm Label: GROUP RECEIVING MASSOTHERAPY- HYPOPRESSIVE ABDOMINAL GYMNASTIC; Type: EXPERIMENTAL; Interventions: Procedure: GROUP RECEIVING MASSOTHERAPY- HYPOPRESSIVE ABDOMINAL GYMNASTIC | Arm Label: GROUP RECEIVING MASSOTHERAPY; Type: EXPERIMENTAL; Interventions: Procedure: GROUP RECEIVING MASSOTHERAPY | Arm Label: GROUP RECEIVING HYPOPRESSIVE ABDOMINAL GYMNASTIC; Type: EXPERIMENTAL; Interventions: Procedure: GROUP RECEIVING HYPOPRESSIVE ABDOMINAL GYMNASTIC | Intervention Type: PROCEDURE; Name: GROUP RECEIVING MASSOTHERAPY- HYPOPRESSIVE ABDOMINAL GYMNASTIC; Assigned to Arm(s): GROUP RECEIVING MASSOTHERAPY- HYPOPRESSIVE ABDOMINAL GYMNASTIC | Intervention Type: PROCEDURE; Name: GROUP RECEIVING MASSOTHERAPY; Assigned to Arm(s): GROUP RECEIVING MASSOTHERAPY | Intervention Type: PROCEDURE; Name: GROUP RECEIVING HYPOPRESSIVE ABDOMINAL GYMNASTIC; Assigned to Arm(s): GROUP RECEIVING HYPOPRESSIVE ABDOMINAL GYMNASTIC
C: Arm Label: kUNDALINI YOGA; Type: EXPERIMENTAL; Interventions: Behavioral: Kundalini yoga | Arm Label: Self care advice to stay active; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Self care advice | Arm Label: Exercise; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Exercise | Intervention Type: BEHAVIORAL; Name: Kundalini yoga; Assigned to Arm(s): kUNDALINI YOGA | Intervention Type: BEHAVIORAL; Name: Self care advice; Assigned to Arm(s): Self care advice to stay active | Intervention Type: BEHAVIORAL; Name: Exercise; Assigned to Arm(s): Exercise
D: Arm Label: 1; Type: EXPERIMENTAL; Interventions: Behavioral: Yoga | Arm Label: 2; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Exercise | Arm Label: 3; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Self-care book recommendations | Intervention Type: BEHAVIORAL; Name: Yoga; Assigned to Arm(s): 1 | Intervention Type: BEHAVIORAL; Name: Exercise; Assigned to Arm(s): 2 | Intervention Type: BEHAVIORAL; Name: Self-care book recommendations; Assigned to Arm(s): 3

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Effect of Yoga Vs. Stretching on Chronic Back Pain
Brief Summary: This study will compare the effectiveness of yoga classes, exercise classes, and a self-care book in the management of pain and function for people with low back pain.It will also for physical, psychological and physiological factors associated with improvement in back pain.


Options:
A: Arm Label: Yoga; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Weekly yoga classes | Arm Label: Physical Therapy; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Individual physical therapy treatment | Arm Label: Education; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Education | Intervention Type: BEHAVIORAL; Name: Weekly yoga classes; Assigned to Arm(s): Yoga | Intervention Type: BEHAVIORAL; Name: Individual physical therapy treatment; Assigned to Arm(s): Physical Therapy | Intervention Type: BEHAVIORAL; Name: Education; Assigned to Arm(s): Education
B: Intervention Type: BEHAVIORAL; Name: Yoga; Assigned to Arm(s): N/A | Intervention Type: BEHAVIORAL; Name: Exercise; Assigned to Arm(s): N/A
C: Arm Label: 1; Type: EXPERIMENTAL; Interventions: Behavioral: Yoga | Arm Label: 2; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Exercise | Arm Label: 3; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Self-care book recommendations | Intervention Type: BEHAVIORAL; Name: Yoga; Assigned to Arm(s): 1 | Intervention Type: BEHAVIORAL; Name: Exercise; Assigned to Arm(s): 2 | Intervention Type: BEHAVIORAL; Name: Self-care book recommendations; Assigned to Arm(s): 3
D: Arm Label: Yoga Class Twice Per Week; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Yoga class twice per week | Arm Label: Yoga Class Once per Week; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Yoga class once per week | Intervention Type: BEHAVIORAL; Name: Yoga class once per week; Assigned to Arm(s): Yoga Class Once per Week | Intervention Type: BEHAVIORAL; Name: Yoga class twice per week; Assigned to Arm(s): Yoga Class Twice Per Week

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Effect of Yoga Vs. Stretching on Chronic Back Pain
Brief Summary: This study will compare the effectiveness of yoga classes, exercise classes, and a self-care book in the management of pain and function for people with low back pain.It will also for physical, psychological and physiological factors associated with improvement in back pain.


Options:
A: Arm Label: Education; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Education | Arm Label: Yoga; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Yoga | Intervention Type: BEHAVIORAL; Name: Education; Assigned to Arm(s): Education | Intervention Type: BEHAVIORAL; Name: Yoga; Assigned to Arm(s): Yoga
B: Arm Label: Hatha Yoga; Type: EXPERIMENTAL; Interventions: Other: Yoga: Active Hatha | Arm Label: Restorative Yoga; Type: ACTIVE_COMPARATOR; Interventions: Other: Yoga: Restorative | Intervention Type: OTHER; Name: Yoga: Active Hatha; Assigned to Arm(s): Hatha Yoga | Intervention Type: OTHER; Name: Yoga: Restorative; Assigned to Arm(s): Restorative Yoga
C: Arm Label: 1; Type: EXPERIMENTAL; Interventions: Behavioral: Yoga | Arm Label: 2; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Exercise | Arm Label: 3; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Self-care book recommendations | Intervention Type: BEHAVIORAL; Name: Yoga; Assigned to Arm(s): 1 | Intervention Type: BEHAVIORAL; Name: Exercise; Assigned to Arm(s): 2 | Intervention Type: BEHAVIORAL; Name: Self-care book recommendations; Assigned to Arm(s): 3
D: Arm Label: Yoga Class Twice Per Week; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Yoga class twice per week | Arm Label: Yoga Class Once per Week; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Yoga class once per week | Intervention Type: BEHAVIORAL; Name: Yoga class once per week; Assigned to Arm(s): Yoga Class Once per Week | Intervention Type: BEHAVIORAL; Name: Yoga class twice per week; Assigned to Arm(s): Yoga Class Twice Per Week

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Effects of Integrated Treatment to Persons With Mental Disorders and Co-occurring Substance Use Disorders
Brief Summary: The purpose of this study is to determine whether Integrated Treatment is effective in the treatment of anxiety and/or depression with co-occurring substance use disorders.


Options:
A: Arm Label: CBT-AD; Type: EXPERIMENTAL; Interventions: Behavioral: CBT-AD | Arm Label: ETAU; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: ETAU | Intervention Type: BEHAVIORAL; Name: CBT-AD; Assigned to Arm(s): CBT-AD | Intervention Type: BEHAVIORAL; Name: ETAU; Assigned to Arm(s): ETAU
B: Arm Label: No intervention; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Communities That Care Intervention; Type: EXPERIMENTAL; Interventions: Behavioral: Communities That Care | Intervention Type: BEHAVIORAL; Name: Communities That Care; Assigned to Arm(s): Communities That Care Intervention
C: Arm Label: Integrated treatment; Type: EXPERIMENTAL; Interventions: Behavioral: Integrated mental health and substance use treatment | Arm Label: Treatment as usual; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Treatment as usual | Intervention Type: BEHAVIORAL; Name: Integrated mental health and substance use treatment; Assigned to Arm(s): Integrated treatment | Intervention Type: BEHAVIORAL; Name: Treatment as usual; Assigned to Arm(s): Treatment as usual
D: Arm Label: 1; Type: EXPERIMENTAL; Interventions: Behavioral: Contingency Management | Arm Label: 2; Type: OTHER; Interventions: Behavioral: Non Contingent Control Condition | Intervention Type: BEHAVIORAL; Name: Contingency Management; Assigned to Arm(s): 1 | Intervention Type: BEHAVIORAL; Name: Non Contingent Control Condition; Assigned to Arm(s): 2

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Phase 4 Study A Large Streamline Safety Study Designed to Compare the Cardiovascular Safety od Celecoxib Versus Traditional Non-selective NSAID's
Brief Summary: The Standard Care versus Celecoxib Outcome Trial (SCOT) is a large streamline safety study designed to compare the cardiovascular safety of celecoxib versus traditional non-selective Non Steroidal Anti-Inflammatory Drug (NSAID) therapy.Traditional NSAID's are associated with significant morbidity and mortality from gastrointestinal toxicity. Cyclooxygenase 2 (Cox-2)selective agents are associated with reduced upper gastrointestinal toxicity.Traditional NSAID's and Cox-2 inhibitors may also be associated with cardiovascular and renal disorders. Data from both randomised and observational studies suggest that celecoxib has similar or reduced cardiovascular toxicity when compared to traditional NSAID's. However, the overall safety balance of a strategy of celecoxib therapy versus a strategy of NSAID therapy is unknown. The European Medicines Evaluation Agency (EMEA) has requested that studies of the cardiovascular safety of celecoxib be carried out within the indicated population of Europe. This study addresses these issues by comparing the cardiovascular safety of celecoxib therapy with traditional NSAID therapy in the setting of the EU healthcare system.

As of May 2013, 7300 patients had been randomised, and had accrued an average 4.2 years of follow up by the end of May 2014.


Options:
A: Arm Label: Fecal Occult Blood Test; Type: ACTIVE_COMPARATOR; Interventions: Other: Fecal occult blood test | Arm Label: Virtual Colonoscopy; Type: ACTIVE_COMPARATOR; Interventions: Procedure: Virtual colonoscopy | Arm Label: Optical Colonoscopy; Type: ACTIVE_COMPARATOR; Interventions: Procedure: Optical colonoscopy | Intervention Type: OTHER; Name: Fecal occult blood test; Assigned to Arm(s): Fecal Occult Blood Test | Intervention Type: PROCEDURE; Name: Virtual colonoscopy; Assigned to Arm(s): Virtual Colonoscopy | Intervention Type: PROCEDURE; Name: Optical colonoscopy; Assigned to Arm(s): Optical Colonoscopy
B: Arm Label: 1; Type: EXPERIMENTAL; Interventions: Dietary Supplement: Vitamin A or Beta-Carotene Supplements | Arm Label: 2; Type: EXPERIMENTAL; Interventions: Dietary Supplement: Vitamin A or Beta-Carotene Supplements | Arm Label: 3; Type: PLACEBO_COMPARATOR; Interventions: Dietary Supplement: Vitamin A or Beta-Carotene Supplements | Intervention Type: DIETARY_SUPPLEMENT; Name: Vitamin A or Beta-Carotene Supplements; Assigned to Arm(s): 1, 2, 3
C: Arm Label: Celecoxib; Type: EXPERIMENTAL; Interventions: Drug: Celecoxib | Arm Label: Diclofenac; Type: ACTIVE_COMPARATOR; Interventions: Drug: Diclofenac | Intervention Type: DRUG; Name: Celecoxib; Assigned to Arm(s): Celecoxib | Intervention Type: DRUG; Name: Diclofenac; Assigned to Arm(s): Diclofenac
D: Arm Label: Culturally-tailored video; Type: OTHER; Interventions: Behavioral: Culturally-tailored video | Intervention Type: BEHAVIORAL; Name: Culturally-tailored video; Assigned to Arm(s): Culturally-tailored video

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Overactive Bladder Innovative Therapy Trial
Brief Summary: The purpose of this study is to compare percutaneous tibial nerve stimulation (PTNS) to drug therapy for the treatment of symptoms of overactive bladder (OAB).


Options:
A: Arm Label: Percutaneus Stimulation; Type: ACTIVE_COMPARATOR; Interventions: Procedure: Percutaneus Stimulation | Arm Label: Transcutaneous Stimulation; Type: EXPERIMENTAL; Interventions: Device: Transcutaneous Stimulation | Intervention Type: DEVICE; Name: Transcutaneous Stimulation; Assigned to Arm(s): Transcutaneous Stimulation | Intervention Type: PROCEDURE; Name: Percutaneus Stimulation; Assigned to Arm(s): Percutaneus Stimulation
B: Arm Label: Urgent PC; Type: ACTIVE_COMPARATOR; Interventions: Device: Urgent PC Neuromodulation System | Arm Label: Sham / Placebo; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: DEVICE; Name: Urgent PC Neuromodulation System; Assigned to Arm(s): Urgent PC
C: Arm Label: Urgent PC treatment arm; Type: EXPERIMENTAL; Interventions: Device: Urgent PC Neuromodulation System, Drug: Tolterodine | Intervention Type: DEVICE; Name: Urgent PC Neuromodulation System; Assigned to Arm(s): Urgent PC treatment arm | Intervention Type: DRUG; Name: Tolterodine; Assigned to Arm(s): Urgent PC treatment arm
D: Arm Label: Urgent PC; Type: ACTIVE_COMPARATOR; Interventions: Device: Urgent PC | Intervention Type: DEVICE; Name: Urgent PC; Assigned to Arm(s): Urgent PC

Answer: C